Nachrichten zur Merck & Co. Inc. Aktie

Will Merck (MRK) Beat Estimates Again in Its Next Earnings Report?

Merck (MRK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…

Heres Why Merck (MRK) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why…

„Das schlechteste Land in Europa“ – Das Ende des britischen Pharma-Traums

Plötzlich blasen AstraZeneca, Merck und andere Konzerne große Investitionen in Großbritannien ab. Einst galt der Staat als attraktiver Standort für…

Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales

LONDON and RALEIGH, N.C., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a…

Earnings call transcript: Merck Q2 2025 highlights innovation and growth By Investing.com

Earnings call transcript: Merck Q2 2025 highlights innovation and growth…

Merck Aktie: DAX Gewinner am 03. Oktober - Technisch stabil, fundamental attraktiv

Frankfurt (www.aktiencheck.de) - Merck-Aktienanalyse von XTB:Die Experten von XTB nehmen die Aktie der Merck KGaA (ISIN: DE0006599905, WKN: 659990, Ticker-Symbol:…

Merck: Wochengewinner in KW 40 im DAX!

Merck ISIN: DE0006599905 konnte im Wochenverlauf 13,37 Prozent zulegen. Mit diesem Kursgewinn war das "Wissenschafts- und Technologieunternehmen" aus Darmstadt der…

Merck: A Race Against The Keytruda Clock

…

MRK Stock Up Nearly 14% So Far This Week: Whats Driving It?

Merck shares climb nearly 14% as Pfizers landmark drug pricing deal with the Trump administration sparked renewed optimism in pharma…

DAX-Analyse: Siemens, Siemens Energy & Zalando zünden den Turbo - Merck, Bayer & MTU tauchen ab - Der große DAX-Check

Bad Marienberg (www.aktiencheck.de) -DAX Gewinner treiben den Markt: Siemens, Siemens Energy & Zalandozünden den Turbo – Merck, Bayer & MTU…

Is It Worth Investing in Merck (MRK) Based on Wall Streets Bullish Views?

According to the average brokerage recommendation (ABR), one should invest in Merck (MRK). It is debatable whether this highly sought-after…

Merck Aktie: DAX Gewinner am 01. Oktober - Kurssprung von 10% als Start einer Trendwende?

Frankfurt (www.aktiencheck.de) - Merck-Aktienanalyse von XTB:Die Experten von XTB nehmen die Aktie der Merck KGaA (ISIN: DE0006599905, WKN: 659990, Ticker-Symbol:…

Eli Lilly, Merck Lead Market Cap Stock Movers on Wednesday By Investing.com

Eli Lilly, Merck Lead Market Cap Stock Movers on Wednesday…

Is Veevas Vault CRM Emerging as the Standard for Top Biopharma?

VEEVs Vault CRM is gaining traction with top biopharma firms like Merck, Gilead, and BMS, signaling its rise as the…

Merck (MRK) Outperforms Broader Market: What You Need to Know

In the closing of the recent trading day, Merck (MRK) stood at $78.56, denoting a +1.24% move from the preceding…

DAX mit Zollsorgen - Bayer, Merck, Nordex, Rheinmetall, Salzgitter und Zalando im Check

Nachdem der deutsche Leitindex am Donnerstag erneut den Rückwärtsgang eingelegt und die 21-Tage-Linie nicht überwunden hat, dürfte der Start in…

MRK vs. BMY: Which Pharma Stock Is the Smarter Pick Now?

Merck and Bristol Myers face diverging growth paths, with Keytruda driving MRKs momentum and BMY navigating generic headwinds.…

Merck: 25% Total Return CAGR Potential

…

Heres Why Merck (MRK) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.…

AKTIE IM FOKUS: Merck dämmen Kursverluste ein - Chefwechsel kommt gut an

FRANKFURT (dpa-AFX) - Die Bestellung des neuen Konzernchefs Kai Beckmannhat bei Merck KGaA am Donnerstag zumindest für etwas Erleichterung…

JPMorgan belässt Merck KGaA auf Overweight - Ziel 155 Euro

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Merck KGaA auf "Overweight" mit einem Kursziel von…

Merck Aktie: Fundamentale Stärke und klare Schwäche im Kursverlauf

Frankfurt (www.aktiencheck.de) - Merck-Aktienanalyse von XTB:Die Merck-Aktie (ISIN: DE0006599905, WKN: 659990, Ticker-Symbol: MRK, NASDAQ OTC-Symbol: MKGAF) zeigt seit mehreren Jahren…

Merck (MRK) Stock Sinks As Market Gains: Heres Why

The latest trading day saw Merck (MRK) settling at $80.4, representing a -1.36% change from its previous close.…

Will the FDAs Nod for Subcutaneous Keytruda Ease Mercks Headwinds?

FDA clears MRKs Keytruda Qlex, a subcutaneous option that promises faster treatment and new patent protection amid looming headwinds.…

Undercovered Dozen: Applied Digital, Merck, B2Gold And More

…

Can MRKs New Drugs Drive Long-Term Growth Amid Looming Keytruda LOE?

Merck eyes new launches like Capvaxive and Winrevair, among others, to drive long-term growth as Keytruda nears loss of exclusivity.…

United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda

The United States Pharmaceutical Market is projected to reach $979.25 billion by 2033, from $638.86 billion in 2024, at a…

ROUNDUP 2/Schwacher Dollar: Merck verfehlt Erwartungen - Neue Prognose

(neu: Aussagen aus der Pressekonferenz, Details, Analyst, Aktienkurs) DARMSTADT (dpa-AFX) - Die Dollar-Schwäche hat dem Merck-Konzern …

ROUNDUP/Schwacher Dollar: Merck verfehlt Erwartungen - Neue Prognose

DARMSTADT (dpa-AFX) - Die Dollar-Schwäche hat dem Merck-Konzern ein unerwartet schwaches zweites Quartal eingebrockt. Zwar konnten die Darmstädter organisch…

Pharmabranche: Währungseffekte belasten Merck – Prognose erneut gestutzt

Der deutsche Pharmakonzern verpasst beim operativen Ergebnis die Erwartungen. Und auch der Ausblick fällt trüb aus. Dabei wachsen die zwei…

Schwacher Dollar: Umsatz- und Ergebniseinbußen für Merck - Nochmals neue Ziele

DARMSTADT (dpa-AFX) - Die Dollar-Schwäche hat beim Darmstädter Merck-Konzern für ein unerwartet schwaches zweites Quartal gesorgt. Der Umsatz ging um…

Exelixis EXEL Q2 2025 Earnings Call Transcript

Image source: The Motley Fool. DATEMonday, July 28, 2025 at 9:00 p.m. ETCALL PARTICIPANTSPresident & CEO — Michael M. MorrisseyChief Financial…

Opko Health (OPK) Q2 Revenue Falls 14%

Key PointsRevenue (GAAP) missed expectations, falling to $156.8 million in Q2 2025—down approximately 14% from the prior year quarter and…

Global New Material International schließt transformative Übernahme des Surface-Solutions-Geschäfts von Merck ab und beschleunigt damit seine globale Expansion

Global New Material International Holdings Limited: Frankfurt (ots/PRNewswire) - Global New Material International Holdings Limited („GNMI" oder „die Gruppe") (6616.HK),…

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days

Trump posted individual letters he sent 17 drugmakers, including Eli Lilly, GSK, Pfizer, Regeneron, Merck, Pfizer and Novo Nordisk.…

Merck Stock Is Almost A Classical Benjamin Graham Investment

…

Merck extends pause on China Gardasil shipments to year end, shares slip

Merck said on Tuesday it was extending its pause on Gardasil shipments to China until at least the end of…

Merck to extend pause on China Gardasil shipments to year end

Merck & Co said on Tuesday it was extending its hold on Gardasil shipments to China until at least the…

Merck Stock Falls After Layoff Announcement, Gardasil Sales Drop

Merck stock fell early Tuesday after Q2 results. The Dow Jones drugmaker plans for job cuts as part of restructuring…

Merck & Co Aktie: Kostenreduzierungen geplant

Wien (www.aktiencheck.de) - Merck & Co-Aktienanalyse der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), nimmt…

Merck & Co will umstruktieren und gesparte Milliarden investieren

RAHWAY (dpa-AFX) - Der Pharmakonzern Merck & Co plant nach einem Umsatz- und Gewinnrückgang im…

Merck Posts Q2 EPS Beat Revenue Slips

Key Points- Non-GAAP EPS of $2.13 topped estimates by $0.11 in Q2 2025; GAAP revenue of $15.8 billion missed by…

Merck plans $3 billion cost cuts by end of 2027, narrows full-year outlook

The multi-year effort comes as Merck prepares to offset revenue losses from the upcoming patent expiration of its blockbuster cancer…

Merck to cut jobs and costs as demand for Gardasil in China remains weak By Reuters

Merck to cut jobs and costs as demand for Gardasil in China remains weak…

Merck posts Q2 earnings miss, unveils cost-cutting initiative

Merck & Co Inc (NYSE:MRK, ETR:6MK) shares moved lower in early trade as the pharmaceutical company reported second quarter earnings…

Merck Q2 Earnings Top, Sales Meet Estimates, 2025 View Narrowed

MRK beats second-quarter estimates for EPS while matching the same for sales. The company trims its 2025 outlook.…

The Best High-Yield Dividend ETF to Own for the Next 10 Years

Key PointsCompanies must pass key tests to be included in the Schwab U.S. Dividend Equity ETF.This fund has averaged a…

U.S. Biomarkers Market Forecast 2025-2034 Featuring Analysis of Roche, Merck, Thermo Fisher Scientific, QIAGEN and Other Industry Leaders

Key growth drivers include rising demands for high-sensitivity diagnostics and personalized medicine, advancements in genomics, proteomics, and AI-driven innovations, and…

This Healthcare Stocks Revolutionary Drug Could Make Early Investors Rich

Key PointsSummit Therapeutics leading candidate is showing promise in a key oncology market.The medicine could earn plenty of indications across…

3 Monster Stocks in the Making to Buy Right Now

Key PointsCRISPR Therapeutics is still in its early growth stage.Summit Therapeutics has plenty of upside potential remaining.Viking Therapeutics is targeting…